Digital Pathology Market: Market Size & Forecast 2026

Digital pathology replaces conventional glass-slide microscopy with digitized whole-slide images that pathologists can view, analyze, and share electronically. The market was valued at approximately $1.2 billion in 2025 and is expanding at roughly 12% annually. The technology encompasses hardware scanners, image-management software, storage infrastructure, and increasingly sophisticated AI-powered diagnostic tools that assist in detecting and quantifying tissue features.

• •Market valued at approximately $1.2 billion in 2025 with approximately 12% annual growth rate
• •Encompasses whole-slide imaging scanners, software platforms, storage systems, and AI analysis tools
• •Serves anatomic pathology laboratories, hospitals, research institutions, and pharmaceutical companies

Rising global cancer incidence is driving demand for more efficient diagnostic workflows, as pathology remains central to cancer diagnosis, staging, and treatment planning. Advances in computational pathology and artificial intelligence are enhancing the speed, accuracy, and reproducibility of image analysis, making digital workflows increasingly attractive to laboratories. Additionally, healthcare systems are seeking to reduce diagnostic turnaround times and enable remote consultation, particularly in underserved regions.

• •Growing cancer prevalence worldwide increasing demand for pathology services and digital workflows
• •AI and machine learning improving diagnostic accuracy, reducing turnaround times, and enabling remote consultation
• •Shift toward personalized medicine requiring quantitative, reproducible analysis of tissue samples

The market is commonly segmented by product type into scanners, software, and storage systems, with whole-slide imaging scanners representing the largest hardware category. By application, key segments include drug discovery and development, clinical disease diagnosis, and academic research. Geographically, North America currently leads adoption due to advanced healthcare infrastructure, while Asia-Pacific is expected to grow fastest as healthcare digitization expands across the region.

• •Product segments: whole-slide scanners, image management software, and storage/communication systems
• •Applications span clinical diagnostics, pharmaceutical R&D, and academic research
• •North America leads in adoption, with Asia-Pacific emerging as the fastest-growing regional market

What are the recent trends and outlook?

AI-assisted diagnostics are becoming increasingly integrated into digital pathology platforms, with algorithms now capable of detecting cancer cells, measuring biomarkers, and predicting patient outcomes from tissue samples. Multi-modal integration combining pathology with genomic and radiological data is emerging as a key trend to support comprehensive precision medicine approaches. Over the next several years, continued market growth is expected, with the market potentially reaching between approximately $2.1 billion and $2.9 billion by 2030-2031 depending on adoption rates and technological advances.

• •AI and machine learning increasingly embedded in pathology workflows for automated detection and quantification
• •Multi-modal integration combining pathology with genomics, radiology, and clinical data becoming standard
• •Market projected to reach between approximately $2.1 billion and $2.9 billion by 2030-2031